Pierfausto Seneci

Scopus Author ID ResearcherID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 12

Top Venues

Pharmaceuticals (Basel, Switzerland)

Journal of medicinal chemistry

RSC advances

Nature communications

Università degli Studi di Milano

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi di Milano

Italy

PA a tempo pieno :: Chemistry

CISI scrl

Italy

Consultant - R&D :: Research and Development

Università degli Studi di Milano

Italy

PA a tempo definito :: Chemistry

NiKem Research

Italy

Consultant - Business Development :: Management

Crystax

Spain

Consultant - Business Development :: Management

NAD AG

Germany

Chief Scientific Officer, then Chief Executive Officer :: Management

Glaxo Wellcome

Italy

Laboratory Head, then Director :: Lead Discovery

SmithKline Beecham

France

Laboratory Head :: Chemistry

Selectide Corporation

United States

Visiting Scientist :: Combinatorial Chemistry

Gruppo Lepetit

Italy

Senior Scientist, then Team Leader :: Chemistry

Marion Merrell Dow

France

Visiting Scientist :: Chemistry

Gruppo Lepetit

Italy

Scientist :: Chemistry

Pierrel SpA

Italy

Junior Scientist :: Chemistry

Publications

Marina Saresella, Chiara Paola Zoia, Francesca La Rosa, Chiara Bazzini, Gessica Sala, Erica Grassenis, Ivana Marventano, Ambra Hernis, Federica Piancone, Elisa Conti, Silvia Sesana, Francesca Re, Pierfausto Seneci, Carlo Ferrarese, Mario Salvatore Clerici
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Roberta Mancuso, Lorenzo Agostino Citterio, Simone Agostini, Ivana Marventano, Francesca La Rosa, Francesca Re, Pierfausto Seneci, Marina Saresella, Mario Salvatore Clerici
Glibenclamide-Loaded Nanoparticles Reduce NLRP3 Inflammasome Activation and Modulate miR-223-3p/miR-7-1-5p Expression in THP-1 Cells. Pharmaceuticals (Basel, Switzerland) 16 (11) (2023)
Silvia Picciolini, Francesca Rodà, Alice Gualerzi, Valentina Mangolini, Luana Forleo, Aurora Mangolini, Silvia Sesana, Antonia Antoniou, Francesca Re, Pierfausto Seneci, Marzia Bedoni
SPRi analysis of molecular interactions of mApoE-functionalized liposomes as drug delivery systems for brain diseases. The Analyst (2023)
Martina Pedrini, Angelo Iannielli, Lorenzo Meneghelli, Daniele Passarella, Vania Broccoli, Pierfausto Seneci
Synthesis and Preliminary Characterization of Putative Anle138b-Centered PROTACs against α-Synuclein Aggregation. Pharmaceutics 15 (5) (2023)
Marina Saresella, Chiara Paola Zoia, Francesca La Rosa, Chiara Bazzini, Gessica Sala, Erica Grassenis, Ivana Marventano, Ambra Hernis, Federica Piancone, Elisa Conti, Silvia Sesana, Francesca Re, Pierfausto Seneci, Carlo Ferrarese, Mario Salvatore Clerici
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Antonia I Antoniou, Giulia Nordio, Maria Luisa Di Paolo, Eleonora Colombo, Beatrice Gaffuri, Laura Polito, Arianna Amenta, Pierfausto Seneci, Aída Nelly García-Argáez, Dario Perdicchia, Daniele Passarella
2-Hydroxyoleic Acid as a Self-Assembly Inducer for Anti-Cancer Drug-Centered Nanoparticles. Pharmaceuticals (Basel, Switzerland) 16 (5) (2023)
Eleonora Colombo, Stefania Olla, Cristina Minnelli, Alessia Formato, Caterina Veroni, Silvia Corbisiero, Mattia Pericolo, Chiara Siguri, Giovanna Mobbili, Cristina Agresti, Pierfausto Seneci
Synthesis and Characterization of Edaravone Analogues as Remyelinating Agents and Putative Mechanistic Probes. Molecules (Basel, Switzerland) 28 (19) (2023)
Eleonora Colombo, Davide Andrea Coppini, Simone Maculan, Pierfausto Seneci, Benedetta Santini, Filippo Testa, Lucia Salvioni, Giovanni Maria Vanacore, Miriam Colombo, Daniele Passarella
Folic acid functionalization for targeting self-assembled paclitaxel-based nanoparticles. RSC advances 12 (54) (2022)
Eleonora Colombo, Davide Andrea Coppini, Simone Maculan, Pierfausto Seneci, Benedetta Santini, Filippo Testa, Lucia Salvioni, Giovanni Maria Vanacore, Miriam Colombo, Daniele Passarella
Folic acid functionalization for targeting self-assembled paclitaxel-based nanoparticles. RSC advances 12 (54) (2022)
Davide Gornati, Roselia Ciccone, Antonio Vinciguerra, Stefania Ippati, Anna Pannaccione, Tiziana Petrozziello, Erika Pizzi, Amal Hassan, Eleonora Colombo, Stefano Barbini, Mario Milani, Cecilia Caccavone, Pietro Randazzo, Luca Muzio, Lucio Annunziato, Andrea Menegon, Agnese Secondo, Eloise Mastrangelo, Giuseppe Pignataro, Pierfausto Seneci
Synthesis and Characterization of Novel Mono- and Bis-Guanyl Hydrazones as Potent and Selective ASIC1 Inhibitors Able to Reduce Brain Ischemic Insult. Journal of medicinal chemistry 64 (12) (2021)
Pasquale Russomanno, Giulia Assoni, Jussara Amato, Vincenzo Maria D'Amore, Riccardo Scaglia, Diego Brancaccio, Martina Pedrini, Giovanna Polcaro, Valeria La Pietra, Paolo Orlando, Marianna Falzoni, Linda Cerofolini, Stefano Giuntini, Marco Fragai, Bruno Pagano, Greta Donati, Ettore Novellino, Cristina Quintavalle, Gerolama Condorelli, Francesco Sabbatino, Pierfausto Seneci, Daniela Arosio, Stefano Pepe, Luciana Marinelli
Interfering with the Tumor-Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 Inhibitors. Journal of medicinal chemistry 64 (21) (2021)
Luca Muzio, Riccardo Sirtori, Davide Gornati, Simona Eleuteri, Andrea Fossaghi, Diego Brancaccio, Leonardo Manzoni, Linda Ottoboni, Luca De Feo, Angelo Quattrini, Eloise Mastrangelo, Luca Sorrentino, Emanuele Scalone, Giancarlo Comi, Luciana Marinelli, Nilo Riva, Mario Milani, Pierfausto Seneci, Gianvito Martino
Retromer stabilization results in neuroprotection in a model of Amyotrophic Lateral Sclerosis. Nature communications 11 (1) (2020)

Pierfausto Seneci.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pierfausto Seneci